Related Articles
Interleukin-28B polymorphisms are associated with an early viral response in patients receiving hepatitis C therapy
Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C
Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection
Prediction of a sustained viral response in chronic hepatitis C patients who undergo induction therapy with double filtration plasmapheresis plus interferon-β/ribavirin
Polymorphism of the inosine triphosphate pyrophosphatase gene predicts ribavirin-induced anemia in chronic hepatitis C patients